Immunochemistry Diagnostic Devices And Equipment Market Analysis: Understanding The Drivers Behind 10.9% CAGR Through 2030 Growth
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Immunochemistry Diagnostic Devices And Equipment Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The immunochemistry diagnostic devices and equipment market size has expanded rapidly in recent years. This market is set to grow from $3.67 billion in 2025 to $4.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. The historical expansion can be attributed to several factors including the expansion of clinical diagnostic testing volumes, the rising prevalence of chronic and infectious diseases, the growth in centralized diagnostic laboratories, the increasing use of immunoassays in oncology and endocrinology, and enhancements in laboratory infrastructure.
The market for immunochemistry diagnostic devices and equipment is projected to experience substantial expansion over the coming years. This market is forecast to reach a value of $6.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. The anticipated market growth stems from several factors, including a heightened demand for precise diagnostic tools, the increasing integration of automated laboratory systems, broader applications of personalized medicine, greater investment in sophisticated diagnostic technologies, and a stronger emphasis on identifying diseases earlier. Key trends expected during this period involve the wider adoption of automated immunoassay analyzers, an escalating need for highly sensitive diagnostic reagents, expanded utilization of multiplex testing platforms, the proliferation of laboratory automation solutions, and a heightened commitment to improving workflow efficiency and accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Immunochemistry Diagnostic Devices And Equipment Market Growth Catalysts And Demand Drivers
The increasing need for personalized medicine is projected to boost the immunochemistry diagnostic devices and equipment market. Personalized medicine involves customizing healthcare and treatment plans based on a patient’s distinct genetic, genomic, and clinical traits to enhance outcomes and reduce side effects. This rising demand stems from greater awareness and acceptance of treatments tailored to individual genetic, lifestyle, and environmental factors for better patient results. Such tailored medicine requires advanced immunochemistry assays to pinpoint biomarkers and inform specific treatment plans for individuals. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization advocating for individualized treatment, reported that 20 out of 53 new therapeutic molecular entities cleared by the Food and Drug Administration in 2023, along with six new gene and cell-based therapies, were designated as personalized medicines, making up about 38 percent of all new molecular entities approved in the country. Consequently, the expanding demand for personalized medicine is fueling the growth of the immunochemistry diagnostic devices and equipment market.
Immunochemistry Diagnostic Devices And Equipment Market Segment Breakdown: Which Categories Lead On Revenue?
The immunochemistry diagnostic devices and equipment market covered in this report is segmented –
1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables
2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables
3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development And Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications
4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Immunochemistry Analyzers: Chemiluminescence Immunoassay (CLIA) Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Radioimmunoassay (RIA) Analyzers, Fluorescence Immunoassay (FIA) Analyzers
2) By Immunochemistry Stainers: Automated Stainers, Manual Stainers
3) By Incubators: CO2 Incubators, Shaking Incubators, Heated Incubators
4) By Microscopes: Light Microscopes, Fluorescence Microscopes, Electron Microscopes
5) By Centrifuges: Microcentrifuges, Refrigerated Centrifuges, Ultracentrifuges
6) By Autoclaves: Tabletop Autoclaves, Vertical Autoclaves, Horizontal Autoclaves
7) By Consumables: Reagents and Kits, Test Plates, Filters and Membranes, Microplates and Accessories
Immunochemistry Diagnostic Devices And Equipment Market Trends Shaping Long-Term Demand
Leading firms within the immunochemistry market are creating innovative products, including multiplex assays, to secure a competitive advantage. These assays are laboratory methods that allow for the concurrent measurement and analysis of several analytes from one biological sample, offering an exhaustive and streamlined method for investigating numerous factors or biomarkers in a solitary experiment. As an illustration, in June 2023, Navigate BioPharma Services, Inc., a US biotechnology firm, introduced novel multiplex digital PCR assays specifically developed for the accurate quantification of chimeric antigen receptor (CAR) T cells, which are a significant advancement in cancer immunotherapy. Utilizing the Qiagen QIAcuity digital PCR System, these assays facilitate the concurrent assessment of CAR-T cell count, activity, and durability in clinical blood and bone marrow specimens, eliminating the requirement for standard curves and identifying CAR-T cells even at concentrations as minimal as 0.01%. This groundbreaking assay supports clinicians in overseeing responses and ensuring safety throughout clinical trials, thereby accelerating the progress of CAR-T therapies due to its high sensitivity, specificity, and efficiency.
Immunochemistry Diagnostic Devices And Equipment Market Key Players Shaping Industry Direction
Major companies operating in the immunochemistry diagnostic devices and equipment market are Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton Dickinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio. Inc, Immucor Inc., Quidel Corporation
View The Full Immunochemistry Diagnostic Devices And Equipment Market Report:
Immunochemistry Diagnostic Devices And Equipment Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the global immunochemistry diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the immunochemistry diagnostic devices and equipment market. The regions covered in the immunochemistry diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
